the aid library

Monthly Update on Monkeypox (MPX) in Nigeria, Epi-week: 17, April 30, 2022

Government of Nigeria (2022) CC

Situation Report

Monkeypox — MPX Fact Sheet

Hesperian (2022) C1

Monkeypox Factsheet in English Hesperian’s fact sheet is one of the first accessible yet comprehensive health resources on Monkeypox. We describe common symptoms of monkeypox, how to prevent its spread, and how it can be treated at home. We also note how the world seems to have learned nothing fr ... more

FICHE D’INFORMATION Vaccination contre la MPX (variole simienne) – avec le vaccin Imvanex® (ou Jynneos®) de Bavarian Nordic

Robert Koch Institut (2023) CC

Fiche d'information

Empfehlungen des RKI zu Hygienemaßnahmen im Rahmen der Behandlung und Pflege von Patienten mit einer Infektion durch Affenpockenviren in Einrichtungen des Gesundheitswesens

Robert Koch Institut (RKI) (2022) C2

Nach dem derzeitigen Informationsstand sind aktuell humane Infektionen durch das Affenpockenvirus (monkeypox virus, MPX) in einigen Regionen der Welt einschließlich mehreren europäischen Ländern aufgetreten. Die Daten belegen eine Mensch-zu-Mensc ... more

Schutzimpfung gegen Affenpocken

Robert-Koch-Institut RKI (2022) CC

Informationsplattform rund um Affenpocken

Affenpocken: Informationen zu Erkankung und Impfung

Bundeszentrale für gesundheitliche Aufklärung BzgA (2022) CC

Seit Mai 2022 treten in Europa und auch in Deutschland Fälle von Affenpocken auf. Die Betroffenen erkranken in der Regel nicht schwer. Aktuelle Informationen über Ansteckung, Symptome, Schutz und Impfung gibt es hier.

2022 Monkeypox Outbreak: Global Trends

World Health Organization WHO (2022) C_WHO

This report provides a global overview of the monkeypox epidemiological situation as reported to WHO

Monkeypox Toolkit: Social Media Tiles

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

Here is what you need to know about monkeypox

What's going on with monkeypox

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

Infographic

Revised National Guidelines on Mpox

Wasif Malik, M.; et al. National Institute of Health, Pakistan (2024) CC

This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.

Multi-country outbreak of mpox, External situation report #42- 9 November 2024

World Health Organisation (WHO) (2024) C_WHO

This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.

Mpox Multi-country external situation report n. 37

World Health Organisation (WHO) (2024) C_WHO

22 September 2024

Monkeypox: case report form (‎CRF)‎, 21 July 2022

World Health Organization WHO (2022) C_WHO

WHO invites Member States, health facilities and other entities to participate in the global effort to collect anonymized clinical data relating to suspected or confirmed cases of monkeypox and contribute data to the WHO Global Clinical Platform. WHO has developed a clinical characterization case ... more

Vaccines and immunization for monkeypox: Interim guidance, 16 November 2022

World Health Organization WHO (2022) C_WHO

The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas ... more

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde ... d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more